메뉴 건너뛰기




Volumn 117, Issue 10, 2009, Pages 593-599

Comparative Study of Low-dose Pioglitazone or Metformin Treatment in Ia pa nese Diabetic Patients with Metabolic Syndrome

Author keywords

Atherosclerosis; Metabolic syndrome; Metformin; Pioglitazone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PIOGLITAZONE; TRIACYLGLYCEROL;

EID: 70450265353     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1202792     Document Type: Article
Times cited : (13)

References (51)
  • 1
    • 25144459980 scopus 로고    scopus 로고
    • The metabolic syndrome - A new worldwide definition
    • DOI 10.1016/S0140-6736(05)67402-8, PII S0140673605674028
    • Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062 (Pubitemid 41338752)
    • (2005) Lancet , vol.366 , Issue.9491 , pp. 1059-1062
    • Alberti, K.G.M.M.1    Zimmet, P.2    Shaw, J.3
  • 2
    • 0033754530 scopus 로고    scopus 로고
    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study
    • AranoffS,RosenblattS,BraithwalteSetal. Pioglitazonehydrochloridemonotherapy improvesglycemiccontrolinthetreatmentofpatientswithtype2diabetes: A6-monthrandomizedplacebo-controlleddose-responsestudy: ThePioglitazone001StudyGrouDiabetesCare2000;23:1605-1611(Pubitemid30812632)
    • (2000) Diabetes Care , vol.23 , Issue.11 , pp. 1605-1611
    • Aronoff, S.1    Rosenblatt, S.2    Braithwaite, S.3    Egan, J.W.4    Mathisen, A.L.5    Schneider, R.L.6
  • 3
    • 0022531205 scopus 로고
    • Anorectic effect of metformin in lean and genetically obese hyperglycemic (ob/ob) mice
    • Bailey CJ, Flatt PR, Ewan C. Anorectic effect of metformin in lean and genetically obese hyperglycemic (ob/ob) mice. Arch Int Pharmacodyn Ther 1986; 282: 233-239
    • (1986) Arch Int Pharmacodyn Ther , Issue.282 , pp. 233-239
    • Bailey, C.J.1    Flatt, P.R.2    Ewan, C.3
  • 5
    • 1442275315 scopus 로고    scopus 로고
    • Definitions of the insulin resistance syndrome: The 1 st World Congress on the Insulin Resistance Syndrome
    • Bioomgarden ZT. Definitions of the insulin resistance syndrome : the 1 st World Congress on the Insulin Resistance Syndrome. Diabetes Care 2004; 27: 824-830
    • (2004) Diabetes Care , vol.27 , pp. 824-830
    • Bioomgarden, Z.T.1
  • 6
    • 0029142479 scopus 로고
    • Blood pressure lowering by pioglitazone Evidence for adirect vascular effect
    • Buchanan TA, Meehan WP, Jeng YY et al. Blood pressure lowering by pioglitazone Evidence for adirect vascular effect. J Clin Invest 1995; 96: 354-360
    • (1995) J Clin Invest , vol.96 , pp. 354-360
    • Buchanan, T.A.1    Meehan, W.P.2    Jeng, Y.Y.3
  • 9
  • 11
    • 0026021161 scopus 로고
    • Insulin resistance-A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
    • DeFronzo RA, Ferannini E. Insulin resistance-A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173
    • (1991) Diabetes Care , vol.14 , pp. 173
    • Defronzo, R.A.1    Ferannini, E.2
  • 12
    • 0029099086 scopus 로고
    • The multicenter metformin study group Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
    • DeFronzo RA, Goodman AM. The multicenter metformin study group Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 541-549
    • (1995) N Engl J Med , vol.333 , pp. 541-549
    • Defronzo, R.A.1    Goodman, A.M.2
  • 13
    • 26244453309 scopus 로고    scopus 로고
    • PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macrovascular Events); a randomized controlled trial
    • Dormandy JA, Charbonnel B, Eckland DJ étal. PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macrovascular Events); a randomized controlled trial. Lancet 2005; 366:1279-1289
    • (2005) Lancet , vol.366 , pp. 1279-1289
    • Dormandy, J.A.1    Charbonnel, B.2    Eckland, D.J.3
  • 14
    • 31444436197 scopus 로고    scopus 로고
    • Examination Committee for Metabolic SyndromeDiagnostic Criteria: Japanese Metabolic Syndrome Diagnostic Criteria
    • Examination Committee for Metabolic SyndromeDiagnostic Criteria: Japanese Metabolic Syndrome Diagnostic Criteria. J Jpn Soc Intern Med 2005; 94: 794-809
    • (2005) J Jpn Soc Intern Med , vol.94 , pp. 794-809
  • 15
    • 0035897696 scopus 로고    scopus 로고
    • Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesteivl in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
    • (2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesteivl in Adults , vol.285 , pp. 2486-2497
  • 16
    • 0031472452 scopus 로고    scopus 로고
    • Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial
    • DOI 10.1016/S0002-9343(97)00254-4, PII S0002934397002544
    • Garber AJ, Duncan TG, Goodman AM et al. Efficacy of metformin type II diabetes-results of a double-blind. Placebo-controlled, doseresponse trial. Am J Med 1997; 102: 491-497 (Pubitemid 28018651)
    • (1997) American Journal of Medicine , vol.103 , Issue.6 , pp. 491-497
    • Garber, A.J.1    Duncan, T.G.2    Goodman, A.M.3    Mills, D.J.4    Rohlf, J.L.5
  • 17
    • 0034986314 scopus 로고    scopus 로고
    • Comparison of effects of thiazolidinediones on cardiovascular risk factor: Observations from aclinical practice
    • Gegick CG, Altheimer MD. Comparison of effects of thiazolidinediones on cardiovascular risk factor : observations from aclinical practice. Endocr Pract2001; 7: 162-169
    • (2001) Endocr Pract , vol.7 , pp. 162-169
    • Gegick, C.G.1    Altheimer, M.D.2
  • 19
    • 10144224904 scopus 로고    scopus 로고
    • A prospective analysis of the HOMA model: The Mexico City Diabetes Study
    • Haffner SM, Kennedy E, Gonzalez C et al. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 1996; 19: 1138-1141
    • (1996) Diabetes Care , vol.19 , pp. 1138-1141
    • Haffner, S.M.1    Kennedy, E.2    Gonzalez, C.3
  • 21
    • 1042268736 scopus 로고    scopus 로고
    • Quartet Study Group, One-year glycémie control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
    • Hanefeld M, Brunetti P, Schernthaner GH et al. Quartet Study Group, One-year glycémie control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes. Diabetes Care 2004; 27: 141-147
    • (2004) Diabetes Care , vol.27 , pp. 141-147
    • Hanefeld, M.1    Brunetti, P.2    Schernthaner, G.H.3
  • 23
    • 0037116638 scopus 로고    scopus 로고
    • Oral antihyperglycemic therapy for type 2 diabetes: Scientific review
    • InzucchiSE.Oralantihyperglycemictherapyfortype2diabetes:scientificreview. JAMA2002;287:360-372(Pubitemid34256388)
    • (2002) Journal of the American Medical Association , vol.287 , Issue.3 , pp. 360-372
    • Inzucchi, S.E.1
  • 24
    • 0024391834 scopus 로고
    • The deadly qualtet-Upper body obesity, glucose intolerance, hyperglyceridemia, and hypertension
    • Kaplan NM. The deadly qualtet-Upper body obesity, glucose intolerance, hyperglyceridemia, and hypertension-. Arch Intern Med 1989; 149:1514
    • (1989) Arch Intern Med , vol.149 , pp. 1514
    • Kaplan, N.M.1
  • 25
    • 10444243290 scopus 로고    scopus 로고
    • Effects of pioglitazone on the components of diabetic dyslipidaemia: Results of double-blind, multicenter, randomised studies
    • DOI 10.1111/j.1368-5031.2004.00258.x
    • Khan M, XU Y, Edwards G et al. Effects of pioglitazone on the components of diabetic dyslipidaemia: results of double-blind, multicentre, randomised studies. Mariz Int J Clin Prat 2004; 58: 907-912 (Pubitemid 39642610)
    • (2004) International Journal of Clinical Practice , vol.58 , Issue.10 , pp. 907-912
    • Khan, M.1    Xu, Y.2    Edwards, G.3    Urquhart, R.4    Mariz, S.5
  • 26
    • 0035883890 scopus 로고    scopus 로고
    • Metformin in non-alcoholic steatohepatitis
    • Marchesini G, Brizi M, Blanchi G et al. Metformin in non-alcoholic steatohepatitis. Lancet 2002; 358: 893-894
    • (2002) Lancet , vol.358 , pp. 893-894
    • Marchesini, G.1    Brizi, M.2    Blanchi, G.3
  • 27
    • 0032779351 scopus 로고    scopus 로고
    • Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines Adipocytederived Bioctive Substances
    • Matsuzawa Y, Funahashi T, Nakamura T. Molecular Mechanism of Metabolic Syndrome X : Contribution of Adipocytokines Adipocytederived Bioctive Substances. Ann NY Acad Sei 1999; 892:146
    • (1999) Ann NY Acad Sci , vol.892 , pp. 146
    • Matsuzawa, Y.1    Funahashi, T.2    Nakamura, T.3
  • 28
    • 0017737946 scopus 로고
    • Phenformin-associated lactic acidosis: Pathogenesis and treatment
    • Misbin RI. Phenformin-associated lactic acidosis : pathogenesis and treatment. Ann Intern Med 1977; 87: 591
    • (1977) Ann Intern Med , vol.87 , pp. 591
    • Misbin, R.I.1
  • 29
    • 0030065814 scopus 로고    scopus 로고
    • Genetic analysis of the 1RS: Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
    • Mitchell BD, Kammerer CM, Mahaney MC et al. Genetic analysis of the 1RS : Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vase Biol 1996; 16: 281-288
    • (1996) Arterioscler Thromb Vase Biol , vol.16 , pp. 281-288
    • Mitchell, B.D.1    Kammerer, C.M.2    Mahaney, M.C.3
  • 30
    • 0031003829 scopus 로고    scopus 로고
    • Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes
    • DOI 10.1016/S0895-7061(96)00406-2, PII S0895706196004062
    • Morikang E, Benson SC, Kurtz TW et al. Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myoeytes. Am J Hypertens. 1997; 10: 440-446 (Pubitemid 27195980)
    • (1997) American Journal of Hypertension , vol.10 , Issue.4 I , pp. 440-446
    • Morikang, E.1    Benson, S.C.2    Kurtz, T.W.3    Pershadsingh, H.A.4
  • 31
    • 0027399661 scopus 로고
    • Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects
    • A study of two ethnic groups.
    • Nagi DK, Yudkin JS. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. Diabetes Care 1993; 16: 621-629
    • (1993) Diabetes Care , vol.16 , pp. 621-629
    • Nagi, D.K.1    Yudkin, J.S.2
  • 32
    • 33746588255 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American diabetes association and the European association for the study of diabetes
    • DOI 10.2337/dc06-9912
    • Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972 (Pubitemid 44156663)
    • (2006) Diabetes Care , vol.29 , Issue.8 , pp. 1963-1972
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Heine, R.J.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7
  • 34
    • 0027983920 scopus 로고
    • Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
    • DOI 10.1056/NEJM199411033311803
    • Nolan JJ, Ludvik KB, Beerdsen P et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;331: 1188-1193 (Pubitemid 24331336)
    • (1994) New England Journal of Medicine , vol.331 , Issue.18 , pp. 1188-1193
    • Nolan, J.J.1    Ludvik, B.2    Beerdsen, P.3    Joyce, M.4    Olefsky, J.5
  • 35
    • 70450285558 scopus 로고    scopus 로고
    • Effective remedy against edema and increased weight caused by pioglitazone - Examination on 2 cases with type ii diabetes who have responded to pioglitazone
    • Otsuka A. Effective remedy against edema and increased weight caused by pioglitazone - examination on 2 cases with type ii diabetes who have responded to pioglitazone. Prog Med 2004; 24: 1809-1812
    • (2004) Prog Med , vol.24 , pp. 1809-1812
    • Otsuka, A.1
  • 37
    • 14644427817 scopus 로고    scopus 로고
    • Impact of waist circumference on the relationship between blood pressure and insulin: The Quebec health survey
    • DOI 10.1161/01.HYP.0000155463.90018.dc
    • Poirier P, Lemieux I, Mawiège P et al. Impact of waist circumference on the relationship between blood pressure and insulin : the Quebec Health Survey. Hypertension 2005; 45: 363-367 (Pubitemid 40315804)
    • (2005) Hypertension , vol.45 , Issue.3 , pp. 363-367
    • Poirier, P.1    Lemieux, I.2    Mauriege, P.3    Dewailly, E.4    Blanchet, C.5    Bergeron, J.6    Despres, J.-P.7
  • 39
    • 0034098771 scopus 로고    scopus 로고
    • Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes
    • Rasfein P, Rappaport EB, Cole ST, Yan Y et al. Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes. Diabetologia 2000; 43: 278-284
    • (2000) Diabetologia , vol.43 , pp. 278-284
    • Rasfein, P.1    Rappaport, E.B.2    Cole, S.T.3    Yan, Y.4
  • 40
    • 0024160877 scopus 로고
    • Role of insulin resistance in human disease
    • Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595
    • (1988) Diabetes , vol.37 , pp. 1595
    • Reaven, G.M.1
  • 41
    • 70450235490 scopus 로고    scopus 로고
    • Affects on weight fluctuations caused by metformin hydrochloride treatment in patients with type II diabetes
    • Shimizu H, Uehara Y, Masunaga M et al. Affects on weight fluctuations caused by metformin hydrochloride treatment in patients with type II diabetes. Prog Med 2002; 22: 450-453
    • (2002) Prog Med , vol.22 , pp. 450-453
    • Shimizu, H.1    Uehara, Y.2    Masunaga, M.3
  • 42
    • 0030989050 scopus 로고    scopus 로고
    • 2+currents and not endothelial nitric oxide production
    • 2+currents and not endothelial nitric oxide production. Diabetes 1997; 46: 659-664
    • (1997) Diabetes , vol.46 , pp. 659-664
    • Song, J.1    Walsh, M.F.2    Igwe, R.3
  • 43
    • 0031977203 scopus 로고    scopus 로고
    • Insulin-induced vasodilation and endothelial function in obesity/insulin resistance: Effects of troglitazone
    • Tack CL, Ong MK, Lutterman JA et al. Insulin-induced vasodilation and endothelial function in obesity/insulin resistance: effects of troglitazone. Diabetologia 1998; 41: 569-576
    • (1998) Diabetologia , vol.41 , pp. 569-576
    • Tack, C.L.1    Ong, M.K.2    Lutterman, J.A.3
  • 44
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34)
    • UK Prospective Diiabetes Study (UKPDS) Group
    • UK Prospective Diiabetes Study (UKPDS) Group Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34). Lancet 1998; 352: 854-865
    • (1998) Lancet , vol.352 , pp. 854-865
  • 45
    • 0003285983 scopus 로고    scopus 로고
    • Definition, diagnosis and classification of diabetes mellitus and its complications
    • World Health Organization. World Health Organization, Geneva
    • World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva; 1999
    • (1999) Part I: Diagnosis and Classification of Diabetes Mellitus.
  • 46
    • 3042541843 scopus 로고    scopus 로고
    • The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: A systematic review
    • DOI 10.1111/j.1365-2796.2004.01328.x
    • Wulffele MG, Kooy A, Zeeuw D de et al. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type2 diabetes mellitus : a systematic review. J Intern Med 2004; 256: 1-14 (Pubitemid 38813614)
    • (2004) Journal of Internal Medicine , vol.256 , Issue.1 , pp. 1-14
    • Wulffele, M.G.1    Kooy, A.2    De Zeeuw, D.3    Stehouwer, C.D.A.4    Gansevoort, R.T.5
  • 47
    • 0035798713 scopus 로고    scopus 로고
    • The mechanisms by which both heterozygous PPARa deficiency and PPARa agonist improve insulin resistance
    • Yamauchi T, Kamon J, Waki H et al. The mechanisms by which both heterozygous PPARa deficiency and PPARa agonist improve insulin resistance. J Biol Chem 2001a; 276: 41245-41254
    • (2001) J Biol Chem , vol.276 , pp. 41245-41254
    • Yamauchi, T.1    Kamon, J.2    Waki, H.3
  • 50
    • 0028305598 scopus 로고
    • Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity
    • Zhang HY, Ready SR, Kotchen TA. Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension 1994; 24: 106-110
    • (1994) Hypertension , vol.24 , pp. 106-110
    • Zhang, H.Y.1    Ready, S.R.2    Kotchen, T.A.3
  • 51
    • 0034773404 scopus 로고    scopus 로고
    • Role of AMP-activated protein kinase in mechanism of metformin action
    • Zhou G, Myers R, Li Y et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2004; 108: 1167-1174
    • (2004) J Clin Invest , vol.108 , pp. 1167-1174
    • Zhou, G.1    Myers, R.2    Li, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.